3/30/2015 - 3:43 PM EST - Catamaran Corporation : announced a combination with OptumRx, UnitedHealth Group's free-standing pharmacy care services business. The agreement calls for the acquisition of Catamaran's outstanding common stock for $61.50 per share in cash. The transaction is expected to close during the fourth quarter of 2015, subject to Catamaran shareholders' approval, regulatory approvals and other customary closing conditions. Catamaran Corporation
shares T.CCT are trading up $15.14 at $75.98.